CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 40 filers reported holding CTI BIOPHARMA CORP in Q3 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,560,496 | -31.4% | 847,737 | -1.8% | 0.00% | 0.0% |
| Q4 2022 | $5,189,070 | +10.8% | 863,406 | +7.3% | 0.00% | 0.0% |
| Q3 2022 | $4,682,000 | +3.8% | 804,519 | +6.5% | 0.00% | 0.0% |
| Q2 2022 | $4,510,000 | +619.3% | 755,419 | +463.0% | 0.00% | – |
| Q1 2022 | $627,000 | +86.1% | 134,185 | -1.1% | 0.00% | – |
| Q4 2021 | $337,000 | -9.7% | 135,693 | +7.5% | 0.00% | – |
| Q3 2021 | $373,000 | +18.0% | 126,259 | 0.0% | 0.00% | – |
| Q2 2021 | $316,000 | +7.5% | 126,259 | +25.3% | 0.00% | – |
| Q1 2021 | $294,000 | -7.0% | 100,753 | +2.7% | 0.00% | – |
| Q4 2020 | $316,000 | +41.1% | 98,115 | -6.0% | 0.00% | – |
| Q3 2020 | $224,000 | +98.2% | 104,402 | +7.2% | 0.00% | – |
| Q2 2020 | $113,000 | +8.7% | 97,371 | -14.0% | 0.00% | – |
| Q1 2020 | $104,000 | -26.2% | 113,273 | +27.2% | 0.00% | – |
| Q4 2019 | $141,000 | +60.2% | 89,062 | -15.1% | 0.00% | – |
| Q3 2019 | $88,000 | -81.0% | 104,865 | -80.5% | 0.00% | – |
| Q2 2019 | $463,000 | -16.0% | 538,290 | -5.2% | 0.00% | – |
| Q1 2019 | $551,000 | +31.8% | 567,723 | -0.5% | 0.00% | – |
| Q4 2018 | $418,000 | -66.1% | 570,506 | -0.0% | 0.00% | – |
| Q3 2018 | $1,233,000 | -57.5% | 570,787 | -2.0% | 0.00% | -100.0% |
| Q2 2018 | $2,900,000 | +582.4% | 582,522 | +434.3% | 0.00% | – |
| Q1 2018 | $425,000 | +308.7% | 109,024 | +181.5% | 0.00% | – |
| Q4 2017 | $104,000 | -15.4% | 38,725 | 0.0% | 0.00% | – |
| Q3 2017 | $123,000 | -3.9% | 38,725 | 0.0% | 0.00% | – |
| Q2 2017 | $128,000 | -21.5% | 38,725 | 0.0% | 0.00% | – |
| Q1 2017 | $163,000 | – | 38,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |